{"id":27714,"date":"2025-08-05T14:02:39","date_gmt":"2025-08-05T21:02:39","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/?p=27714"},"modified":"2026-04-24T13:29:46","modified_gmt":"2026-04-24T20:29:46","slug":"enhertu-una-terapia-dirigida-para-canceres-avanzados","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/enhertu-a-targeted-therapy-for-advanced-cancers\/","title":{"rendered":"Enhertu: Una terapia dirigida para c\u00e1nceres avanzados"},"content":{"rendered":"<p class=\"wp-block-paragraph\">Cuando se les diagnostica c\u00e1ncer, especialmente si se ha propagado o ha regresado despu\u00e9s del tratamiento, muchos pacientes buscan con urgencia opciones de tratamiento efectivas.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Afortunadamente, el avance continuo en el tratamiento del c\u00e1ncer ha tra\u00eddo una nueva esperanza en forma de un medicamento dirigido llamado Enhertu.&nbsp;<\/p>\n\n\n\n<div  id=\"call-to-action-f73b52697c0e5a67d6c765080aabf404\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tObtenga asistencia financiera para Enhertu\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<p class=\"wp-block-paragraph\">Enhertu (fam-trastuzumab deruxtecan-nxki) es la primera y m\u00e1s eficaz terapia dirigida al c\u00e1ncer para tratar una variedad de c\u00e1nceres dif\u00edciles de tratar, particularmente aquellos que son HER2 positivos, HER2 bajos o HER2 ultra bajos.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Este art\u00edculo detalla todo lo que necesita saber sobre Enhertu, incluidos los tipos de c\u00e1ncer que trata, c\u00f3mo funciona, c\u00f3mo usarlo, efectos secundarios t\u00edpicos y m\u00e1s.&nbsp;<\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_85 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Alternar tabla de contenido\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Palanca<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/enhertu-a-targeted-therapy-for-advanced-cancers\/#What_Is_Enhertu\" >\u00bfQu\u00e9 es Enhertu?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/enhertu-a-targeted-therapy-for-advanced-cancers\/#What_Type_of_Cancers_Does_Enhertu_Treat\" >\u00bfQu\u00e9 tipos de c\u00e1ncer trata Enhertu?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/enhertu-a-targeted-therapy-for-advanced-cancers\/#How_Effective_is_Enhertu_for_Patients\" >\u00bfQu\u00e9 tan efectivo es el Enhertu para los pacientes?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/enhertu-a-targeted-therapy-for-advanced-cancers\/#How_It_Works\" >C\u00f3mo funciona<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/enhertu-a-targeted-therapy-for-advanced-cancers\/#Enhertu_Working_Mechanism\" >Mecanismo de trabajo Enhertu<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/enhertu-a-targeted-therapy-for-advanced-cancers\/#How_Is_Enhertu_Administered_and_What_Is_Its_Recommended_Dosage\" >\u00bfC\u00f3mo se administra Enhertu y cu\u00e1l es su dosis recomendada?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/enhertu-a-targeted-therapy-for-advanced-cancers\/#Under_What_Conditions_Is_Enhertu_Taken\" >\u00bfBajo qu\u00e9 condiciones se toma Enhertu?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/enhertu-a-targeted-therapy-for-advanced-cancers\/#What_Are_the_Possible_Side_Effects\" >\u00bfCu\u00e1les son los posibles efectos secundarios?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/enhertu-a-targeted-therapy-for-advanced-cancers\/#What_Should_I_Tell_My_Healthcare_Provider_Before_Taking_Enhertu\" >\u00bfQu\u00e9 debo decirle a mi proveedor de atenci\u00f3n m\u00e9dica antes de tomar Enhertu?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/enhertu-a-targeted-therapy-for-advanced-cancers\/#Is_Enhertu_a_Chemotherapy_or_Immunotherapy\" >\u00bfEnhertu es una quimioterapia o inmunoterapia?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/enhertu-a-targeted-therapy-for-advanced-cancers\/#How_Much_Does_It_Cost\" >\u00bfCu\u00e1nto cuesta?<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Is_Enhertu\"><\/span><strong>\u00bfQu\u00e9 es Enhertu?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Enhertu (tambi\u00e9n conocido por su nombre gen\u00e9rico, fam-trastuzumab deruxtecan-nxki) es un conjugado anticuerpo-f\u00e1rmaco (ADC)<strong>,<\/strong> lo que significa que contiene dos componentes activos que est\u00e1n vinculados entre s\u00ed:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>A <strong>anticuerpo monoclonal <\/strong>(trastuzumab) que se dirige a una prote\u00edna marcadora espec\u00edfica llamada receptor 2 del factor de crecimiento epid\u00e9rmico humano (HER2) presente en la superficie de algunas c\u00e9lulas cancerosas.<\/li>\n\n\n\n<li>A <strong>medicaci\u00f3n de quimioterapia <\/strong>(deruxtecan o DXd) que se une al anticuerpo y se administra directamente a las c\u00e9lulas cancerosas.<\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\">Enhertu pertenece a la clase de medicamentos inhibidores de HER2 y fue aprobado por primera vez por la FDA en diciembre de 2019.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Type_of_Cancers_Does_Enhertu_Treat\"><\/span><strong>\u00bfQu\u00e9 tipos de c\u00e1ncer trata Enhertu?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">La Administraci\u00f3n de Alimentos y Medicamentos de los Estados Unidos (FDA) aprob\u00f3 inicialmente el Enhertu para el tratamiento de pacientes adultas con c\u00e1ncer de mama irresecable o metast\u00e1sico HER2-positivo que se han sometido a dos o m\u00e1s tratamientos previos basados en anti-HER2. Desde entonces, el Enhertu ha sido aprobado a nivel mundial para el tratamiento de varias otras indicaciones, entre ellas:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>C\u00e1ncer de mama HER2 positivo<\/li>\n\n\n\n<li>C\u00e1ncer de mama con HER2 bajo<\/li>\n\n\n\n<li>C\u00e1ncer de mama con receptor hormonal (HR) positivo, HER2 bajo o HER2 ultrabaja<\/li>\n\n\n\n<li>C\u00e1ncer de est\u00f3mago o de la uni\u00f3n gastroesof\u00e1gica avanzado HER2 positivo<\/li>\n\n\n\n<li>C\u00e1ncer de pulm\u00f3n de c\u00e9lulas no peque\u00f1as (CPCNP) con mutaci\u00f3n HER2<\/li>\n\n\n\n<li>Tumores s\u00f3lidos HER2 positivos con mutaciones HER2<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">En resumen, Enhertu puede no s\u00f3lo ayudar a pacientes con tumores HER2 positivos tradicionales sino tambi\u00e9n a aquellos con c\u00e1nceres con HER2 bajo o HER2 mutado que anteriormente eran dif\u00edciles de tratar.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_Effective_is_Enhertu_for_Patients\"><\/span><strong>\u00bfQu\u00e9 tan efectivo es el Enhertu para los pacientes?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">El Enhertu mostr\u00f3 resultados prometedores durante los ensayos cl\u00ednicos. Por ejemplo, en comparaci\u00f3n con la quimioterapia, el Enhertu... <a href=\"https:\/\/www.nejm.org\/doi\/abs\/10.1056\/NEJMoa2407086\">redujo el riesgo de progresi\u00f3n del c\u00e1ncer o muerte en un 36%<\/a> En pacientes con c\u00e1ncer de mama metast\u00e1sico con HR positivo, HER2 bajo o HER2 ultrabajo. En promedio, las pacientes que recibieron Enhertu experimentaron una supervivencia libre de progresi\u00f3n m\u00e1s prolongada (aproximadamente 13 meses), en comparaci\u00f3n con quienes recibieron quimioterapia convencional.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">De manera similar, en estudios sobre c\u00e1ncer de est\u00f3mago y c\u00e1ncer de pulm\u00f3n, Enhertu tambi\u00e9n ha mostrado beneficios significativos, especialmente cuando los tratamientos anteriores han fallado.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Por ejemplo, en pacientes con c\u00e1ncer g\u00e1strico avanzado HER2 positivo tratado previamente, Enhertu <a href=\"https:\/\/www.astrazeneca.com\/media-centre\/press-releases\/2022\/enhertu-approved-in-eu-for-gastric-cancer.html#!\">redujo el riesgo de muerte en 41%<\/a> en comparaci\u00f3n con la quimioterapia.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_It_Works\"><\/span><strong>C\u00f3mo funciona<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Algunas c\u00e9lulas de c\u00e1ncer de mama sobreexpresan HER2 (abreviatura de Receptor 2 del Factor de Crecimiento Epid\u00e9rmico Humano), una prote\u00edna que act\u00faa como una antena en la superficie de las c\u00e9lulas cancerosas. Cuando la prote\u00edna HER2 recibe se\u00f1ales, estimula el crecimiento y la multiplicaci\u00f3n r\u00e1pida de la c\u00e9lula cancerosa. Las pacientes con sobreexpresi\u00f3n del gen HER2 se consideran HER2-positivas.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Algunos tumores tienen niveles m\u00e1s bajos de HER2 y se clasifican como HER2 negativo, HER2 bajo o HER2 ultra bajo.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Enhertu_Working_Mechanism\"><\/span><strong>Mecanismo de trabajo Enhertu<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Enhertu contiene dos partes activas que est\u00e1n unidas entre s\u00ed: un anticuerpo monoclonal llamado trastuzumab y un medicamento de quimioterapia llamado deruxtecan o DXd.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">El trastuzumab est\u00e1 dise\u00f1ado para unirse a las prote\u00ednas HER2 de las c\u00e9lulas cancerosas e impedir que estas estimulen su crecimiento. El trastuzumab tambi\u00e9n activa las c\u00e9lulas inmunitarias que destruyen las c\u00e9lulas cancerosas.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Una vez que el anticuerpo se adhiere a las c\u00e9lulas del c\u00e1ncer de mama, se mueve dentro de las c\u00e9lulas y libera el potente medicamento de quimioterapia (deruxtecan) que mata las c\u00e9lulas cancerosas al bloquear una enzima (prote\u00edna) llamada topoisomerasa I, que participa en la creaci\u00f3n de nuevas c\u00e9lulas cancerosas.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Adem\u00e1s, el Enhertu tambi\u00e9n presenta un &quot;efecto espectador&quot;, lo que significa que destruye las c\u00e9lulas cancerosas vecinas incluso si no expresan las prote\u00ednas HER2. Esto convierte al Enhertu en un tratamiento eficaz y m\u00e1s espec\u00edfico para pacientes con c\u00e1ncer de mama con niveles bajos o ultrabajos de HER2.&nbsp;<\/p>\n\n\n\n<div  id=\"call-to-action-5b0cd828442cf659174b53d3f2896512\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tHabla con un especialista\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tAcerca de la asistencia para copagos\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"#form\">Empezar<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_Is_Enhertu_Administered_and_What_Is_Its_Recommended_Dosage\"><\/span><strong>\u00bfC\u00f3mo se administra Enhertu y cu\u00e1l es su dosis recomendada?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"420\" height=\"280\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/cancer-awareness.jpg\" alt=\"Doctora sosteniendo una cinta rosa para concienciar sobre el c\u00e1ncer de mama.\" class=\"wp-image-27716\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/cancer-awareness.jpg 420w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/cancer-awareness-300x200.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/cancer-awareness-18x12.jpg 18w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/cancer-awareness-330x220.jpg 330w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/cancer-awareness-86x57.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/cancer-awareness-167x111.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/cancer-awareness-280x187.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/cancer-awareness-370x247.jpg 370w\" sizes=\"auto, (max-width: 420px) 100vw, 420px\" \/><\/figure>\n<\/div>\n\n\n<p class=\"wp-block-paragraph\">Enhertu est\u00e1 disponible en forma de polvo liofilizado de 100 mg en un vial de dosis \u00fanica que se reconstituye con 5 <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">ml de agua est\u00e9ril antes de la administraci\u00f3n.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">El Enhertu se administra por v\u00eda intravenosa (en una vena) una vez cada 3 semanas durante un ciclo de tratamiento de 21 d\u00edas. La primera infusi\u00f3n durar\u00e1 m\u00e1s de 90 minutos. Si no experimenta ninguna reacci\u00f3n adversa con el primer tratamiento, las infusiones posteriores suelen durar unos 30 minutos.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Dosis recomendada<\/strong><\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">La dosis recomendada de Enhertu para adultos con c\u00e1ncer irresecable o metast\u00e1sico con HER2 positivo, HR positivo, HER2 bajo o HER2 ultrabaja es de 5,4 mg\/kg. De igual manera, los pacientes con tumores s\u00f3lidos HER2 positivos con mutaciones en HER2 tambi\u00e9n reciben la misma dosis (5,4 mg\/kg).&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Por otra parte, los pacientes con CPNM con mutaci\u00f3n HER2 irresecable o metast\u00e1sico<strong> <\/strong>recibir una dosis de 6,4 mg\/kg una vez cada 3 semanas mientras el tratamiento siga siendo eficaz.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Under_What_Conditions_Is_Enhertu_Taken\"><\/span><strong>\u00bfBajo qu\u00e9 condiciones se toma Enhertu?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Enhertu puede considerarse en las siguientes condiciones:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Tiene c\u00e1ncer de mama con HER2 positivo o HER2 bajo.&nbsp;<\/li>\n\n\n\n<li>Su c\u00e1ncer se ha propagado a otras partes del cuerpo (hace met\u00e1stasis).<\/li>\n\n\n\n<li>Su c\u00e1ncer no se puede eliminar con cirug\u00eda.<\/li>\n\n\n\n<li>Su c\u00e1ncer ha regresado durante o dentro de los seis meses de tratamientos previos, como tratamientos dirigidos a HER2 o terapia endocrina.<\/li>\n\n\n\n<li>Tiene tumores s\u00f3lidos avanzados de est\u00f3mago, pulm\u00f3n u otros tumores s\u00f3lidos HER2 positivos.<\/li>\n\n\n\n<li>Los tratamientos anteriores ya no funcionan y su c\u00e1ncer a\u00fan arroja resultados positivos para la expresi\u00f3n o mutaci\u00f3n de HER2.<\/li>\n\n\n\n<li>No tiene otras opciones de tratamiento satisfactorias.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Are_the_Possible_Side_Effects\"><\/span><strong>\u00bfCu\u00e1les son los posibles efectos secundarios?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Los efectos secundarios m\u00e1s comunes notificados durante los ensayos cl\u00ednicos son los siguientes:&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>N\u00e1useas<\/li>\n\n\n\n<li>V\u00f3mitos<\/li>\n\n\n\n<li>Diarrea<\/li>\n\n\n\n<li>Constipaci\u00f3n<\/li>\n\n\n\n<li>Poco apetito<\/li>\n\n\n\n<li>Cansancio<\/li>\n\n\n\n<li>Recuento bajo de gl\u00f3bulos blancos (leucopenia)<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Recuento bajo de gl\u00f3bulos rojos (anemia)<\/li>\n\n\n\n<li>Recuento bajo de plaquetas (trombocitopenia)<\/li>\n\n\n\n<li>Pruebas de funci\u00f3n hep\u00e1tica elevadas<\/li>\n\n\n\n<li>P\u00e9rdida de cabello (alopecia)<\/li>\n\n\n\n<li>Niveles bajos de potasio en la sangre<\/li>\n\n\n\n<li>Dolor muscular o \u00f3seo<br><\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Aunque es poco com\u00fan, Enhertu tambi\u00e9n puede causar <a href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/761139s000lbl.pdf\">algunos efectos secundarios graves<\/a> como:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Enfermedad pulmonar intersticial (un trastorno que causa cicatrices en los pulmones)<\/li>\n\n\n\n<li>Neumonitis (inflamaci\u00f3n de los pulmones)<\/li>\n\n\n\n<li>Disfunci\u00f3n ventricular izquierda<\/li>\n\n\n\n<li>Neutropenia (recuento bajo de neutr\u00f3filos)<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Si experimenta alguno de los s\u00edntomas anteriores, consulte a su proveedor de atenci\u00f3n m\u00e9dica de inmediato.&nbsp;<\/p>\n\n\n\n<div  id=\"call-to-action-290918536d0e7e28faefd0aa69171541\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tObtenga asistencia con el copago ahora\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\"> (877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Should_I_Tell_My_Healthcare_Provider_Before_Taking_Enhertu\"><\/span><strong>\u00bfQu\u00e9 debo decirle a mi proveedor de atenci\u00f3n m\u00e9dica antes de tomar Enhertu?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Antes de tomar Enhrertu, informe a su proveedor de atenci\u00f3n m\u00e9dica si:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Tiene problemas pulmonares o respiratorios.<\/li>\n\n\n\n<li>Tiene signos o s\u00edntomas de una infecci\u00f3n.<\/li>\n\n\n\n<li>Tiene o ha tenido alg\u00fan problema card\u00edaco.<\/li>\n\n\n\n<li>Est\u00e1 embarazada porque Enhertu puede causar toxicidad embriofetal o defectos de nacimiento graves<\/li>\n\n\n\n<li>Est\u00e1 amamantando o planea hacerlo: Se desconoce si el Enhertu pasa a la leche materna. Debe evitar la lactancia durante el tratamiento y al menos 7 meses despu\u00e9s de su \u00faltima dosis.<\/li>\n\n\n\n<li>Tomar cualquier medicamento con o sin receta, como medicamentos de venta libre, suplementos o productos a base de hierbas.&nbsp;<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Nota:<\/strong> ENHERTU puede causar problemas de fertilidad en los hombres, lo que puede afectar la capacidad de tener hijos.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Is_Enhertu_a_Chemotherapy_or_Immunotherapy\"><\/span><strong>\u00bfEnhertu es una quimioterapia o inmunoterapia?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Enhertu no es como la quimioterapia tradicional (que mata tanto las c\u00e9lulas sanas como las cancerosas) o la inmunoterapia.<strong> <\/strong>(que ayuda al sistema inmunitario a combatir el c\u00e1ncer). En realidad, es una combinaci\u00f3n de quimioterapia y terapia dirigida.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">La parte de anticuerpo de Enhertu encuentra y se adhiere a las c\u00e9lulas cancerosas que tienen la prote\u00edna HER2<strong>,<\/strong> Mientras tanto, el medicamento de quimioterapia (DXd) se administra a la c\u00e9lula para matarla desde adentro.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_Much_Does_It_Cost\"><\/span><strong>\u00bfCu\u00e1nto cuesta?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Enhertu suele ser un medicamento caro y su costo puede variar seg\u00fan la dosis y la cobertura de su seguro.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">En los EE. UU., un solo vial de 100 mg puede costar entre $2,440 y $3,022.76. <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK595132\/table\/t03\/\">costo total del tratamiento Enhertu<\/a> pueden oscilar entre aproximadamente $9,574 y $165,949 por a\u00f1o, dependiendo de la dosis y la duraci\u00f3n del tratamiento. Para reducir sus gastos de bolsillo, puede inscribirse en el programa ENHERTU4U, que ofrece <a href=\"https:\/\/ameripharmaspecialty.com\/es\/enhertu-copay-assistance\/\">asistencia para copagos<\/a> y apoyo al paciente. <a href=\"https:\/\/ameripharmaspecialty.com\/es\/asistencia-financiera\/\">Cont\u00e1ctanos<\/a> Si est\u00e1 interesado en obtener asistencia con el copago para Enhertu.<\/p>","protected":false},"excerpt":{"rendered":"<p>Al ser diagnosticados con c\u00e1ncer, especialmente si se ha propagado o ha reaparecido despu\u00e9s del tratamiento, muchos pacientes buscan urgentemente opciones de tratamiento eficaces. Afortunadamente, los continuos avances en el tratamiento del c\u00e1ncer han tra\u00eddo nuevas esperanzas con el medicamento dirigido llamado Enhertu.<\/p>","protected":false},"author":26,"featured_media":27715,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[13],"tags":[32],"class_list":["post-27714","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cancer","tag-dr-robert-hakim"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Enhertu: A Targeted Therapy for Advanced Cancers<\/title>\n<meta name=\"description\" content=\"This article covers everything you need to know about Enhertu, including the types of cancers it treats, how it works, side effects, and more.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/enhertu-una-terapia-dirigida-para-canceres-avanzados\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Enhertu: A Targeted Therapy for Advanced Cancers\" \/>\n<meta property=\"og:description\" content=\"This article covers everything you need to know about Enhertu, including the types of cancers it treats, how it works, side effects, and more.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/enhertu-una-terapia-dirigida-para-canceres-avanzados\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-05T21:02:39+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-24T20:29:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/breast-cancer-screening.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Robert Hakim, PharmD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Robert Hakim, PharmD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/%e7%99%8c%e7%97%87\\\/enhertu-%e6%98%af%e4%b8%80%e7%a7%8d%e9%92%88%e5%af%b9%e6%99%9a%e6%9c%9f%e7%99%8c%e7%97%87%e7%9a%84%e9%9d%b6%e5%90%91%e7%96%97%e6%b3%95\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/%e7%99%8c%e7%97%87\\\/enhertu-%e6%98%af%e4%b8%80%e7%a7%8d%e9%92%88%e5%af%b9%e6%99%9a%e6%9c%9f%e7%99%8c%e7%97%87%e7%9a%84%e9%9d%b6%e5%90%91%e7%96%97%e6%b3%95\\\/\"},\"author\":{\"name\":\"Dr. Robert Hakim, PharmD\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/#\\\/schema\\\/person\\\/234280933b6e0dcaf47c0c1f40a59759\"},\"headline\":\"Enhertu: A Targeted Therapy for Advanced Cancers\",\"datePublished\":\"2025-08-05T21:02:39+00:00\",\"dateModified\":\"2026-04-24T20:29:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/%e7%99%8c%e7%97%87\\\/enhertu-%e6%98%af%e4%b8%80%e7%a7%8d%e9%92%88%e5%af%b9%e6%99%9a%e6%9c%9f%e7%99%8c%e7%97%87%e7%9a%84%e9%9d%b6%e5%90%91%e7%96%97%e6%b3%95\\\/\"},\"wordCount\":1282,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/%e7%99%8c%e7%97%87\\\/enhertu-%e6%98%af%e4%b8%80%e7%a7%8d%e9%92%88%e5%af%b9%e6%99%9a%e6%9c%9f%e7%99%8c%e7%97%87%e7%9a%84%e9%9d%b6%e5%90%91%e7%96%97%e6%b3%95\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/breast-cancer-screening.jpg\",\"keywords\":[\"Dr. Robert Hakim\"],\"articleSection\":[\"Cancer\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/%e7%99%8c%e7%97%87\\\/enhertu-%e6%98%af%e4%b8%80%e7%a7%8d%e9%92%88%e5%af%b9%e6%99%9a%e6%9c%9f%e7%99%8c%e7%97%87%e7%9a%84%e9%9d%b6%e5%90%91%e7%96%97%e6%b3%95\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/%e7%99%8c%e7%97%87\\\/enhertu-%e6%98%af%e4%b8%80%e7%a7%8d%e9%92%88%e5%af%b9%e6%99%9a%e6%9c%9f%e7%99%8c%e7%97%87%e7%9a%84%e9%9d%b6%e5%90%91%e7%96%97%e6%b3%95\\\/\",\"name\":\"Enhertu: A Targeted Therapy for Advanced Cancers\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/%e7%99%8c%e7%97%87\\\/enhertu-%e6%98%af%e4%b8%80%e7%a7%8d%e9%92%88%e5%af%b9%e6%99%9a%e6%9c%9f%e7%99%8c%e7%97%87%e7%9a%84%e9%9d%b6%e5%90%91%e7%96%97%e6%b3%95\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/%e7%99%8c%e7%97%87\\\/enhertu-%e6%98%af%e4%b8%80%e7%a7%8d%e9%92%88%e5%af%b9%e6%99%9a%e6%9c%9f%e7%99%8c%e7%97%87%e7%9a%84%e9%9d%b6%e5%90%91%e7%96%97%e6%b3%95\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/breast-cancer-screening.jpg\",\"datePublished\":\"2025-08-05T21:02:39+00:00\",\"dateModified\":\"2026-04-24T20:29:46+00:00\",\"description\":\"This article covers everything you need to know about Enhertu, including the types of cancers it treats, how it works, side effects, and more.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/%e7%99%8c%e7%97%87\\\/enhertu-%e6%98%af%e4%b8%80%e7%a7%8d%e9%92%88%e5%af%b9%e6%99%9a%e6%9c%9f%e7%99%8c%e7%97%87%e7%9a%84%e9%9d%b6%e5%90%91%e7%96%97%e6%b3%95\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/%e7%99%8c%e7%97%87\\\/enhertu-%e6%98%af%e4%b8%80%e7%a7%8d%e9%92%88%e5%af%b9%e6%99%9a%e6%9c%9f%e7%99%8c%e7%97%87%e7%9a%84%e9%9d%b6%e5%90%91%e7%96%97%e6%b3%95\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/%e7%99%8c%e7%97%87\\\/enhertu-%e6%98%af%e4%b8%80%e7%a7%8d%e9%92%88%e5%af%b9%e6%99%9a%e6%9c%9f%e7%99%8c%e7%97%87%e7%9a%84%e9%9d%b6%e5%90%91%e7%96%97%e6%b3%95\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/breast-cancer-screening.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/breast-cancer-screening.jpg\",\"width\":1280,\"height\":853,\"caption\":\"Woman receiving screening for breast cancer, a condition that can be treated with Enhertu\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/%e7%99%8c%e7%97%87\\\/enhertu-%e6%98%af%e4%b8%80%e7%a7%8d%e9%92%88%e5%af%b9%e6%99%9a%e6%9c%9f%e7%99%8c%e7%97%87%e7%9a%84%e9%9d%b6%e5%90%91%e7%96%97%e6%b3%95\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Enhertu: A Targeted Therapy for Advanced Cancers\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/#\\\/schema\\\/person\\\/234280933b6e0dcaf47c0c1f40a59759\",\"name\":\"Dr. Robert Hakim, PharmD\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1ce5316336fea18759f2cf91c9f6269796c7cb578013d4d04c78cb734056a87d?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1ce5316336fea18759f2cf91c9f6269796c7cb578013d4d04c78cb734056a87d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1ce5316336fea18759f2cf91c9f6269796c7cb578013d4d04c78cb734056a87d?s=96&d=mm&r=g\",\"caption\":\"Dr. Robert Hakim, PharmD\"},\"description\":\"Dr. Robert Chad Hakim, PharmD, was born and raised in Northridge, CA. He received his pharmacy degree from the University of Wisconsin-Madison School of Pharmacy. The most rewarding part of his job is taking initiative to advance clinical programs that maximize impact on patient care. He has a board certification in critical care (BCCCP), and his areas of expertise are critical care, drug information, general medicine, and cardiology. In his free time, he enjoys traveling.\u00a0\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/author\\\/robert-hakim\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Enhertu: Una terapia dirigida para c\u00e1nceres avanzados","description":"Este art\u00edculo cubre todo lo que necesita saber sobre Enhertu, incluidos los tipos de c\u00e1ncer que trata, c\u00f3mo funciona, efectos secundarios y m\u00e1s.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/enhertu-una-terapia-dirigida-para-canceres-avanzados\/","og_locale":"es_MX","og_type":"article","og_title":"Enhertu: A Targeted Therapy for Advanced Cancers","og_description":"This article covers everything you need to know about Enhertu, including the types of cancers it treats, how it works, side effects, and more.","og_url":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/enhertu-una-terapia-dirigida-para-canceres-avanzados\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2025-08-05T21:02:39+00:00","article_modified_time":"2026-04-24T20:29:46+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/breast-cancer-screening.jpg","type":"image\/jpeg"}],"author":"Dr. Robert Hakim, PharmD","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Robert Hakim, PharmD","Est. reading time":"6 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/zh\/%e7%99%8c%e7%97%87\/enhertu-%e6%98%af%e4%b8%80%e7%a7%8d%e9%92%88%e5%af%b9%e6%99%9a%e6%9c%9f%e7%99%8c%e7%97%87%e7%9a%84%e9%9d%b6%e5%90%91%e7%96%97%e6%b3%95\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/%e7%99%8c%e7%97%87\/enhertu-%e6%98%af%e4%b8%80%e7%a7%8d%e9%92%88%e5%af%b9%e6%99%9a%e6%9c%9f%e7%99%8c%e7%97%87%e7%9a%84%e9%9d%b6%e5%90%91%e7%96%97%e6%b3%95\/"},"author":{"name":"Dr. Robert Hakim, PharmD","@id":"https:\/\/ameripharmaspecialty.com\/vi\/#\/schema\/person\/234280933b6e0dcaf47c0c1f40a59759"},"headline":"Enhertu: A Targeted Therapy for Advanced Cancers","datePublished":"2025-08-05T21:02:39+00:00","dateModified":"2026-04-24T20:29:46+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/%e7%99%8c%e7%97%87\/enhertu-%e6%98%af%e4%b8%80%e7%a7%8d%e9%92%88%e5%af%b9%e6%99%9a%e6%9c%9f%e7%99%8c%e7%97%87%e7%9a%84%e9%9d%b6%e5%90%91%e7%96%97%e6%b3%95\/"},"wordCount":1282,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/vi\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/%e7%99%8c%e7%97%87\/enhertu-%e6%98%af%e4%b8%80%e7%a7%8d%e9%92%88%e5%af%b9%e6%99%9a%e6%9c%9f%e7%99%8c%e7%97%87%e7%9a%84%e9%9d%b6%e5%90%91%e7%96%97%e6%b3%95\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/breast-cancer-screening.jpg","keywords":["Dr. Robert Hakim"],"articleSection":["Cancer"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/zh\/%e7%99%8c%e7%97%87\/enhertu-%e6%98%af%e4%b8%80%e7%a7%8d%e9%92%88%e5%af%b9%e6%99%9a%e6%9c%9f%e7%99%8c%e7%97%87%e7%9a%84%e9%9d%b6%e5%90%91%e7%96%97%e6%b3%95\/","url":"https:\/\/ameripharmaspecialty.com\/zh\/%e7%99%8c%e7%97%87\/enhertu-%e6%98%af%e4%b8%80%e7%a7%8d%e9%92%88%e5%af%b9%e6%99%9a%e6%9c%9f%e7%99%8c%e7%97%87%e7%9a%84%e9%9d%b6%e5%90%91%e7%96%97%e6%b3%95\/","name":"Enhertu: Una terapia dirigida para c\u00e1nceres avanzados","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/vi\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/%e7%99%8c%e7%97%87\/enhertu-%e6%98%af%e4%b8%80%e7%a7%8d%e9%92%88%e5%af%b9%e6%99%9a%e6%9c%9f%e7%99%8c%e7%97%87%e7%9a%84%e9%9d%b6%e5%90%91%e7%96%97%e6%b3%95\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/%e7%99%8c%e7%97%87\/enhertu-%e6%98%af%e4%b8%80%e7%a7%8d%e9%92%88%e5%af%b9%e6%99%9a%e6%9c%9f%e7%99%8c%e7%97%87%e7%9a%84%e9%9d%b6%e5%90%91%e7%96%97%e6%b3%95\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/breast-cancer-screening.jpg","datePublished":"2025-08-05T21:02:39+00:00","dateModified":"2026-04-24T20:29:46+00:00","description":"Este art\u00edculo cubre todo lo que necesita saber sobre Enhertu, incluidos los tipos de c\u00e1ncer que trata, c\u00f3mo funciona, efectos secundarios y m\u00e1s.","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/%e7%99%8c%e7%97%87\/enhertu-%e6%98%af%e4%b8%80%e7%a7%8d%e9%92%88%e5%af%b9%e6%99%9a%e6%9c%9f%e7%99%8c%e7%97%87%e7%9a%84%e9%9d%b6%e5%90%91%e7%96%97%e6%b3%95\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/zh\/%e7%99%8c%e7%97%87\/enhertu-%e6%98%af%e4%b8%80%e7%a7%8d%e9%92%88%e5%af%b9%e6%99%9a%e6%9c%9f%e7%99%8c%e7%97%87%e7%9a%84%e9%9d%b6%e5%90%91%e7%96%97%e6%b3%95\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/zh\/%e7%99%8c%e7%97%87\/enhertu-%e6%98%af%e4%b8%80%e7%a7%8d%e9%92%88%e5%af%b9%e6%99%9a%e6%9c%9f%e7%99%8c%e7%97%87%e7%9a%84%e9%9d%b6%e5%90%91%e7%96%97%e6%b3%95\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/breast-cancer-screening.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/breast-cancer-screening.jpg","width":1280,"height":853,"caption":"Woman receiving screening for breast cancer, a condition that can be treated with Enhertu"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/zh\/%e7%99%8c%e7%97%87\/enhertu-%e6%98%af%e4%b8%80%e7%a7%8d%e9%92%88%e5%af%b9%e6%99%9a%e6%9c%9f%e7%99%8c%e7%97%87%e7%9a%84%e9%9d%b6%e5%90%91%e7%96%97%e6%b3%95\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/zh\/"},{"@type":"ListItem","position":2,"name":"Enhertu: A Targeted Therapy for Advanced Cancers"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/vi\/#website","url":"https:\/\/ameripharmaspecialty.com\/vi\/","name":"Cuidado especializado AmeriPharma\u00ae","description":"Atenci\u00f3n especializada por AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/vi\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/vi\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/vi\/#organization","name":"Atenci\u00f3n especializada de Ameripharma","url":"https:\/\/ameripharmaspecialty.com\/vi\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/vi\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/vi\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/vi\/#\/schema\/person\/234280933b6e0dcaf47c0c1f40a59759","name":"Dr. Robert Hakim, Doctor en Farmacia","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/1ce5316336fea18759f2cf91c9f6269796c7cb578013d4d04c78cb734056a87d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/1ce5316336fea18759f2cf91c9f6269796c7cb578013d4d04c78cb734056a87d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1ce5316336fea18759f2cf91c9f6269796c7cb578013d4d04c78cb734056a87d?s=96&d=mm&r=g","caption":"Dr. Robert Hakim, PharmD"},"description":"El Dr. Robert Chad Hakim, PharmD, naci\u00f3 y creci\u00f3 en Northridge, California. Obtuvo su t\u00edtulo en farmacia en la Facultad de Farmacia de la Universidad de Wisconsin-Madison. Lo m\u00e1s gratificante de su trabajo es tomar la iniciativa para impulsar programas cl\u00ednicos que maximicen el impacto en la atenci\u00f3n al paciente. Cuenta con una certificaci\u00f3n del consejo en cuidados cr\u00edticos (BCCCP) y sus \u00e1reas de especializaci\u00f3n son cuidados cr\u00edticos, informaci\u00f3n sobre medicamentos, medicina general y cardiolog\u00eda. En su tiempo libre, disfruta viajando.\u00a0","url":"https:\/\/ameripharmaspecialty.com\/es\/author\/robert-hakim\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/breast-cancer-screening.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/breast-cancer-screening-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/breast-cancer-screening-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/breast-cancer-screening-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/breast-cancer-screening-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/breast-cancer-screening.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/breast-cancer-screening.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/breast-cancer-screening-18x12.jpg",18,12,true],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/breast-cancer-screening-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/breast-cancer-screening-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/breast-cancer-screening-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/breast-cancer-screening-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/breast-cancer-screening-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/breast-cancer-screening-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/breast-cancer-screening-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/breast-cancer-screening-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/breast-cancer-screening.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Dr. Robert Hakim, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/robert-hakim\/"},"uagb_comment_info":0,"uagb_excerpt":"When diagnosed with cancer \u2014 especially if it has spread or returned after treatment \u2014 many patients urgently search for effective treatment options. Fortunately, the continuous advancement in cancer treatment has brought new hope in the form of targeted medicine called Enhertu.","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/breast-cancer-screening.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/breast-cancer-screening.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/breast-cancer-screening.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/breast-cancer-screening-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/breast-cancer-screening-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/breast-cancer-screening-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/breast-cancer-screening.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/breast-cancer-screening.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/breast-cancer-screening-18x12.jpg",18,12,true],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/breast-cancer-screening-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/breast-cancer-screening-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/breast-cancer-screening-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/breast-cancer-screening-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/breast-cancer-screening-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/breast-cancer-screening-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/breast-cancer-screening-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/breast-cancer-screening-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/breast-cancer-screening.jpg",1280,853,false]},"rttpg_author":{"display_name":"Dr. Robert Hakim, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/robert-hakim\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/es\/category\/cancer\/\" rel=\"category tag\">Cancer<\/a>","rttpg_excerpt":"When diagnosed with cancer \u2014 especially if it has spread or returned after treatment \u2014 many patients urgently search for effective treatment options. Fortunately, the continuous advancement in cancer treatment has brought new hope in the form of targeted medicine called Enhertu.","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/27714","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/comments?post=27714"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/27714\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media\/27715"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media?parent=27714"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/categories?post=27714"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/tags?post=27714"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}